1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Musculoskeletal conditions
  5. Spinal conditions

Risdiplam for treating spinal muscular atrophy

Technology appraisal guidance [TA755] Published: 16 December 2021

  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History

Tools and resources

Tools to help you put the guidance into practice.

Education

  • Questions and answers on the managed access agreement for risdiplam (January 2022)  
  • Managed access agreement PDF 626 KB 16 December 2021  
  • Appendix A: Using other treatments after onasemnogene PDF 124 KB 16 December 2021  
  • Appendix B: Managed access patient agreement form PDF 88 KB 16 December 2021  

Resource impact

  • Resource impact statement  

Guidance into practice

  • About the Into practice guide  
  • Practical steps to improving the quality of care and services using NICE guidance